Magnefy Earns $1.5M Pre-Seed and $304K in NSF Phase I STTR
$1.5M in Pre-Seed Funding to Revolutionize Predictive Maintenance for Critical Power Assets
Azalea Therapeutics Scores an 82M Raise
Therapeutics has bloomed with $82 million in funding and a dual-vector approach that the company hopes can enable permanent genome editing with a single dose.